NCT01149915
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Advanced Myelofibrosis, +25 more
- Locations
-
- University of Texas M.D. Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Explore clinical trials studying Precursor Cell Lymphoblastic Leukemia-Lymphoma. Study availability and eligibility vary by location and protocol.
1,801 public trials
304 recruiting studies
Precursor Cell Lymphoblastic Leukemia-Lymphoma trial results
NCT00056069
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- Comprehensive Cancer Center at University of Alabama at Birmingham Birmingham, Alabama, United States
- University of South Alabama Cancer Research Institute Mobile, Alabama, United States
- Arizona Cancer Center at University of Arizona Health Sciences Center Tucson, Arizona, United States
- Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
NCT01244906
- Conditions
- Bone Marrow Diseases, Chronic Disease, Disease Attributes, +29 more
- Locations
-
- Northside Hospital Atlanta, Georgia, United States
NCT00045500
- Conditions
- Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +40 more
- Locations
-
- Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States
- NCI - Center for Cancer Research Bethesda, Maryland, United States
- Frederick Cancer Research and Development Center Frederick, Maryland, United States
NCT00991133
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Children's Hospital Los Angeles Los Angeles, California, United States
- The Children's Hospital Aurora, Colorado, United States
- Children's Healthcare of Atlanta Atlanta, Georgia, United States
- Children's Memorial Hospital Chicago, Illinois, United States
NCT00060021
- Conditions
- Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +103 more
- Locations
-
- Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States
Completed
LMB-2 Immunotoxin in Treating Young Patients With Relapsed or Refractory Leukemia or Lymphoma
NCT00085150
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Dendritic Cell Sarcoma, Interdigitating, +31 more
- Locations
-
- Winship Cancer Institute of Emory University Atlanta, Georgia, United States
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
- Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States
- Doernbecher Children's Hospital at Oregon Health & Science University Portland, Oregon, United States
Completed
Bryostatin 1 and Interleukin-2 in Treating Patients With Refractory Solid Tumors or Lymphoma
NCT00003993
- Conditions
- Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +43 more
- Locations
-
- National Institute on Aging - Baltimore Baltimore, Maryland, United States
NCT00002765
- Conditions
- Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +47 more
- Locations
-
- Laboratory of Molecular Biology Bethesda, Maryland, United States
- Medicine Branch Bethesda, Maryland, United States
NCT00019656
- Conditions
- Bone Marrow Diseases, Burkitt Lymphoma, Chronic Disease, +39 more
- Locations
-
- Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States
- NCI - Center for Cancer Research Bethesda, Maryland, United States